Valion Bio annual operating expenses
2021
2022
2023
2024
2025
Valion Bio Operating Expenses Growth & History (VBIO)
Valion Bio's operating expenses was $7.9M for fiscal 2025.
View full Valion Bio company overviewValion Bio annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $7.9M | $3.4M | +76.45% |
| 2024 | 2024-12-31 | $4.5M | −$4.1M | −47.54% |
| 2023 | 2023-12-31 | $8.5M | −$1.9M | −17.94% |
| 2022 | 2022-12-31 | $10.4M | $4.8M | +85.83% |
| 2021 | 2021-12-31 | $5.6M | — | — |
Valion Bio quarterly operating expenses
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6.4M | $4.7M | +282.84% |
| Q1 2026 · Mar 31 | 2026-03-31 | $5.6M | $4.3M | +309.15% |
| Q1 2026 · Mar 30 | 2026-03-30 | $5.6M | $4.3M | +309.15% |
| Q4 2025 | 2025-12-31 | $2.5M | $2.4M | +4294.74% |
| Q3 2025 | 2025-09-30 | $2.3M | $863,000 | +58.51% |
| Q2 2025 | 2025-06-30 | $1.7M | $382,000 | +29.48% |
| Q1 2025 | 2025-03-31 | $1.4M | −$271,000 | −16.44% |
| Q4 2024 | 2024-12-31 | $57,000 | −$2.2M | −97.47% |
| Q3 2024 | 2024-09-30 | $1.5M | −$393,000 | −21.04% |
| Q2 2024 | 2024-06-30 | $1.3M | −$890,000 | −40.71% |
| Q1 2024 | 2024-03-31 | $1.6M | −$581,000 | −26.07% |
| Q4 2023 | 2023-12-31 | $2.2M | −$47,000 | −2.05% |
| Q3 2023 | 2023-09-30 | $1.9M | −$779,000 | −29.43% |
| Q2 2023 | 2023-06-30 | $2.2M | −$957,000 | −30.45% |
| Q1 2023 | 2023-03-31 | $2.2M | −$82,000 | −3.55% |
| Q4 2022 | 2022-12-31 | $2.3M | $5,000 | +0.22% |
| Q3 2022 | 2022-09-30 | $2.6M | $1.4M | +120.03% |
| Q2 2022 | 2022-06-30 | $3.1M | $2.1M | +207.53% |
| Q1 2022 | 2022-03-31 | $2.3M | $1.2M | +114.18% |
| Q4 2021 | 2021-12-31 | $2.3M | — | — |
| Q3 2021 | 2021-09-30 | $1.2M | — | — |
| Q2 2021 | 2021-06-30 | $1.0M | — | — |
| Q1 2021 | 2021-03-31 | $1.1M | — | — |
Valion Bio operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, Valion Bio's operating expenses increased from $5.6M to $7.9M, a change of $2.3M. The latest reported quarter, Q2 2026, shows $6.4M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Valion Bio source filings ↗